LIESL v1
Research type
Research Study
Full title
LIESL - London Investigation into diElectric Scanning of Lesions
IRAS ID
222459
Contact name
Steven Allen
Contact email
Sponsor organisation
Royal Marsden NHS Foundation Trust
Clinicaltrials.gov Identifier
Duration of Study in the UK
2 years, 0 months, 1 days
Research summary
The MARIA breast imaging system is a novel CE-marked radio-frequency (RF) medical imaging device. The system employs an electromagnetic imaging technique that exploits the dielectric contrast between normal and cancerous tissues. MARIA is a safe, comfortable imaging system that has the potential to support the early diagnosis of breast cancer. The performance and imaging characteristics of MARIA are not yet well demonstrated. We aim to evaluate some aspects of this potentially important new technology by determining the proportion of patients with breast cancer in whom breast cancer is correctly identified by MARIA. In addition a pilot study will be performed to investigate the imaging characteristics and performance of MARIA in the assessment of benign and malignant lesions in patients attending the symptomatic breast clinic. Women with a confirmed or strongly suspected breast cancer and those attending symptomatic clinics are all eligible. The study is expected to last between 12-24 months and patients will undergo a 5-10 minute scan on the same day as any other planned diagnostic imaging such as a mammography or ultrasound.
REC name
London - London Bridge Research Ethics Committee
REC reference
18/LO/0232
Date of REC Opinion
27 Mar 2018
REC opinion
Further Information Favourable Opinion